Canadian Pharmaceuticals & Biotech Most Popular Stocks

Aptose Biosciences

Market Cap: CA$4.2m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

MindBio Therapeutics

Market Cap: CA$3.4m

Operates as a clinical stage drug development company in Australasia.

City View Green Holdings

Market Cap: CA$3.0m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

Psyence Group

Market Cap: CA$2.6m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Neural Therapeutics

Market Cap: CA$2.5m

A drug discovery company, focuses on plant-based active substances.

Restart Life Sciences

Market Cap: CA$2.5m

Through its subsidiaries, operates as a biotechnology company worldwide.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

Algernon Pharmaceuticals

Market Cap: CA$2.4m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

TILT Holdings

Market Cap: CA$2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.

Appili Therapeutics

Market Cap: CA$1.8m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Pharmadrug

Market Cap: CA$1.6m

Operates as a specialty pharmaceutical company.

Captor Capital

Market Cap: CA$1.6m

Engages in the retail sale of cannabis products in the United States.

Silo Wellness

Market Cap: CA$1.5m

A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.

New Leaf Ventures

Market Cap: CA$1.5m

Engages in processing, packaging, marketing, and distributing cannabis and related products.

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

Adastra Holdings

Market Cap: CA$1.3m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

Entheon Biomedical

Market Cap: CA$1.2m

Operates as a biotechnology research and development company.

Ovation Science

Market Cap: CA$1.2m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Jolt Health

Market Cap: CA$1.1m

Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.

Waverley Pharma

Market Cap: CA$1.1m

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.

Steep Hill

Market Cap: CA$1.1m

Does not have significant operations.

EGF Theramed Health

Market Cap: CA$1.0m

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Lumiera Health

Market Cap: CA$849.8k

Develops and commercializes evidence-based botanical products for the healthcare in Canada.

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

Maven Brands

Market Cap: CA$702.8k

Together with its subsidiary, engages in the production, toll-processing, and packaging of medical cannabis in Canada.

Nirvana Life Sciences

Market Cap: CA$684.7k

Engages in the research and development of therapeutic products and medicines to address addiction.

Aequus Pharmaceuticals

Market Cap: CA$663.2k

Operates as a specialty pharmaceutical company in Canada.

Vaxil Bio

Market Cap: CA$657.5k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Biome Grow

Market Cap: CA$562.1k

Focuses on the cannabis business.